Viscosupplementation is a treatment that involves the injection of a thick gel-like substance into a joint. This gel is usually made up of hyaluronic acid, which is a naturally occurring substance in the human body that helps lubricate joints. The purpose of viscosupplementation is to provide relief to patients with osteoarthritis, a condition in which the cartilage that cushions joints breaks down over time, causing pain and stiffness. The global viscosupplementation market has been growing steadily in recent years, driven by an aging population and an increase in the number of cases of osteoarthritis. According to a report by Astute Analytica, the Global viscosupplementation market was valued at US$ 4,347.8 million in 2022 and is expected to reach US$ 8,958.9 million by 2030 at a CAGR of 8.4% during the forecast period (2023–2030). Key Factors One of the key factors driving the growth of the viscosupplementation market is the increasing prevalence of ost...